Compare MCB & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCB | ETON |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2017 | 2018 |
| Metric | MCB | ETON |
|---|---|---|
| Price | $92.74 | $45.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $98.67 | $39.33 |
| AVG Volume (30 Days) | 140.9K | ★ 524.3K |
| Earning Date | 04-21-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 11.64 | N/A |
| EPS | ★ 4.40 | 0.05 |
| Revenue | $11,053,000.00 | ★ $79,950,000.00 |
| Revenue This Year | $37.22 | $40.90 |
| Revenue Next Year | $14.75 | $47.23 |
| P/E Ratio | ★ $21.10 | $923.60 |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $64.66 | $14.27 |
| 52 Week High | $102.04 | $50.18 |
| Indicator | MCB | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 44.98 | 63.97 |
| Support Level | $86.40 | $15.77 |
| Resistance Level | $93.56 | $50.18 |
| Average True Range (ATR) | 2.63 | 2.56 |
| MACD | -0.13 | -0.08 |
| Stochastic Oscillator | 49.38 | 59.75 |
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.